Key result
A demographics and utilization model accurately discriminates AF from DVT/PE in outpatients starting oral anticoagulants.
Why the study?
Identifying atrial fibrillation in outpatients initiating oral anticoagulants from claims databases is challenging when outpatient indication is unavailable due to overlapping indications such as DVT/PE.
Observational (n=256,418)
Effect estimate: c-index 0.93
An algorithm using medico-administrative claims data can accurately identify atrial fibrillation among outpatients initiating oral anticoagulants, facilitating epidemiological research in large databases.
May facilitate precise AF cohort identification in claims databases; leaves open external validation before research or policy application.
PURPOSE: Identifying atrial fibrillation (AF) in outpatients treated with oral anticoagulants (OACs) from claims databases is challenging when the outpatient indication is not available, as OACs are also prescribed for deep vein thrombosis/pulmonary embolism (DVT/PE) that may be treated in the ambulatory setting. An algorithm was developed to identify AF in outpatients initiating OAC from medico-administrative data. METHODS: Among patients initiating OAC in 2013 in the French healthcare databases, those treated for orthopaedic indications were excluded. Patients with a history of AF or DVT/PE directly identified from available medical data, mainly hospital discharge diagnoses, were considered to be 'confirmed AF or DVT/PE patients'. Demographics of these patients and their healthcare utilization data prior to OAC initiation were then included in a logistic regression model discriminating AF versus DVT/PE indications. The final model selected, comparing c-index, provided an algorithm identifying AF from among initially unclassified patients assumed to be either AF or DVT/PE outpatients. RESULTS: Among 256 418 patients initiating OAC, 37 388 were excluded; 61 329 AF and 59 859 DVT/PE patients were directly identified, leaving 88 488 unclassified patients. The final model (c-index: 0.93) included demographics, cardiologist prescriber, hospitalization for stroke, use of antiarrhythmics/beta-blockers/antihypertensive drugs and undergoing a Holter/echocardiography procedure, thyroid function tests, but no D-dimer tests. With a specificity of 95% (sensitivity: 65%), 41% of the unclassified patients were assumed to be AF outpatients. Similar results were obtained on 250 159 new users in 2014. CONCLUSION: This algorithm combining inpatient and outpatient claims data performed relatively well to identify AF outpatients initiating OAC.
No takes yet. Share an insight, caveat, or question.
Billionnet et al. (2017) conducted an observational in Atrial fibrillation in outpatients initiating oral anticoagulants (n=256,418). Algorithm based on medico-administrative data was evaluated on Discrimination of atrial fibrillation versus DVT/PE indications (c-index 0.93). A logistic regression model using demographics and healthcare utilization data accurately discriminated atrial fibrillation from DVT/PE in outpatients initiating oral anticoagulants (c-index 0.93).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: